Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Hepatitis B vaccine recombinant - VBI Vaccines

Next Previous
X
Search
Drug Profile

Hepatitis B vaccine recombinant - VBI Vaccines

Alternative Names: 3-Antigen HBV Vaccine; 3-Antigen Hepatitis B vaccine; 3-Antigen Prophylactic Hepatitis B Vaccine - VIB Vaccines; 3-Antigen Vaccine; 3A-HBV; Bio-Hep-B; Hepimmune; PreHevbri; PreHevbrio; Sci-B-Vac; Trivalent hepatitis B (HBV) vaccine

Latest Information Update: 22 Nov 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Weizmann Institute of Science
  • Developer VBI Vaccines
  • Class Hepatitis B vaccines; Synthetic vaccines; Virus-like particle vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Hepatitis B

Most Recent Events

  • 15 Nov 2024 Withdrawn for Hepatitis B (Prevention) in USA (IM)
  • 16 Apr 2024 VBI Vaccines in collaboration with Valneva plans to launch Hepatitis B vaccine recombinant for Hepatitis B (Prevention) in additional European Union countries in 2024
  • 14 Feb 2024 Brii Biosciences and VBI Vaccines enter into an agreement for transferring manufacturing technologies of VBI 2601 and Hepatitis B vaccine recombinant to additional manufacturing sites and expanding commercial supplies

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top